0001193125-21-259336.txt : 20210827 0001193125-21-259336.hdr.sgml : 20210827 20210827160603 ACCESSION NUMBER: 0001193125-21-259336 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20210824 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20210827 DATE AS OF CHANGE: 20210827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESMED INC CENTRAL INDEX KEY: 0000943819 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980152841 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15317 FILM NUMBER: 211218922 BUSINESS ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 BUSINESS PHONE: 8587462400 MAIL ADDRESS: STREET 1: 9001 SPECTRUM CENTER BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92123 8-K 1 d196505d8k.htm 8-K 8-K
RESMED INC US CA false 0000943819 0000943819 2021-08-24 2021-08-24

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Under Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

August 24, 2021

 

 

ResMed Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-15317   98-0152841

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

9001 Spectrum Center Blvd.

San Diego, California 92123

(Address of Principal Executive Offices)

(858) 836-5000

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.004 par value   RMD   NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  ☐

 

 

 


Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 24, 2021, we determined that, effective August 25, Rajwant (“Raj”) Sodhi would cease serving as our president – Software-as-a-Service business and will cease full-time employment with us on September 1, 2021. The termination is without cause, and we are in discussions with Mr. Sodhi regarding a separation package.

Effective August 25, 2021, we promoted Bobby Ghoshal, age 53, to serve as our president – Software-as-a-Service business. Mr. Ghoshal has over 25 years of experience across medical and technology industries, with strong experience building and leading high-performing teams to accelerate the adoption of digital platforms across enterprises. He has served as ResMed’s Chief Technology Officer since April 2018. From June 2016 until April 2018, Mr. Ghoshal served as chief operating officer for Brightree, a ResMed-owned provider of cloud-based software-as-a-service for out-of-hospital care. From 2012 until 2016, he was ResMed’s vice president, information technology.

 

2


SIGNATURES

We have authorized the person whose signature appears below to sign this report on our behalf, in accordance with the Securities Exchange Act of 1934.

 

Date: August 27, 2021     RESMED INC.
    (registrant)
    By:  

/s/ David Pendarvis

    Name:   David Pendarvis
    Its:   Chief administrative officer, global general
      counsel and secretary

 

3

EX-101.SCH 2 rmd-20210824.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 rmd-20210824_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Address, Country Entity Address, Country Entity Address, State or Province Entity Address, State or Province Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 4 rmd-20210824_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 d196505d8k_htm.xml IDEA: XBRL DOCUMENT 0000943819 2021-08-24 2021-08-24 RESMED INC US CA false 0000943819 8-K 2021-08-24 DE 001-15317 98-0152841 9001 Spectrum Center Blvd. San Diego 92123 (858) 836-5000 false false false false Common Stock, $0.004 par value RMD NYSE false XML 6 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document and Entity Information
Aug. 24, 2021
Cover [Abstract]  
Entity Registrant Name RESMED INC
Entity Address, Country US
Entity Address, State or Province CA
Amendment Flag false
Entity Central Index Key 0000943819
Document Type 8-K
Document Period End Date Aug. 24, 2021
Entity Incorporation State Country Code DE
Entity File Number 001-15317
Entity Tax Identification Number 98-0152841
Entity Address, Address Line One 9001 Spectrum Center Blvd.
Entity Address, City or Town San Diego
Entity Address, Postal Zip Code 92123
City Area Code (858)
Local Phone Number 836-5000
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.004 par value
Trading Symbol RMD
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d196505d8k.htm rmd-20210824.xsd rmd-20210824_lab.xml rmd-20210824_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d196505d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d196505d8k.htm" ] }, "labelLink": { "local": [ "rmd-20210824_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "rmd-20210824_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "rmd-20210824.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 5 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "rmd", "nsuri": "http://investor.resmed.com/20210824", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d196505d8k.htm", "contextRef": "duration_2021-08-24_to_2021-08-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d196505d8k.htm", "contextRef": "duration_2021-08-24_to_2021-08-24", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://investor.resmed.com//20210824/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 14 0001193125-21-259336-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-259336-xbrl.zip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